GEMER 0.5 MG TAB

1. All Details: Specifications
Dosage Form: Uncoated bilayer tablets (specifically formulated with a prolonged-release layer).
Storage Conditions: Store at room temperature, protected from light and moisture.
Batch Number (B.No.): GTH1121A
Manufacturing Date (Mfg. Dt.): 03/2026
Expiry Date (Exp. Dt.): 02/2028
Manufacturing License Number: M.L.: 374/DR/Mfg/2013
Maximum Retail Price (M.R.P.): Rs. 43.00 per 10 Tablets (Inclusive of all taxes).
Product Authentication Code: 5257512 (printed near the manufacturer details).
2. General
Brand: Gemer® 0.5
Generic Name: Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets IP
Quantity: 10 Tablets per strip (indicated by “per 10 Tablets”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the statutory red caution warning boxes for Schedule G and Schedule H).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from March 2026 to February 2028).
Food Preference / FSSAI: Not Applicable. This product is a critical prescription medication for managing chronic metabolic conditions, not a food product or dietary supplement. It falls strictly under national drug regulation authorities rather than the FSSAI, and it does not display vegetarian or non-vegetarian preference icons.
3. Product Details: Ingredients
Each uncoated bilayer tablet contains:
Metformin Hydrochloride IP (as prolonged-release): 500 mg
Glimepiride IP: 0.5 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Brilliant Blue FCF
4. Directions: How to Use
Administration Guide: Tablet should be swallowed whole and not to be chewed or crushed.
Dosage: As directed by the Physician.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision.
SCHEDULE H PRESCRIPTION DRUG – WARNING: To be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Gemer 0.5 is a fixed-dose combination oral anti-diabetic medication. It combines an insulin-sensitizing agent (Metformin Hydrochloride in a prolonged-release matrix to decrease glucose absorption and production) with a low-dose insulin secretagogue (Glimepiride to stimulate insulin release from the pancreas). It is standardly prescribed under rigorous medical oversight for managing blood sugar levels in adults with Type 2 diabetes mellitus.
Visual Presentation: The packaging features a protective silver metallic blister backing with distinctive patterned orange and teal foil details at the bottom, standard red cautionary notification bars, and a scannable QR code instructing consumers to “Scan QR code and check product authenticity.”
6. Manufacturer Information
Manufactured in India by: sun pharma laboratories ltd.
Factory Address: Vill: Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, List: Kamrup, Assam-781128.
7. Marketed By
Marketed By: Sun Pharmaceutical Industries Ltd.